Gamification in genetics, genomics, and pharmacogenomics education: a bibliometric analysis of research trends, collaboration, and emerging themes (2000–2025) - Scorecard - MDSpire

Gamification in genetics, genomics, and pharmacogenomics education: a bibliometric analysis of research trends, collaboration, and emerging themes (2000–2025)

  • By

  • Azhar T. Rahma

  • Reem AlSheryani

  • Noon Hatim Khalid Alrabee

  • Ahmed Alderei

  • Alnawa Alharthi

  • Asma Alshebli

  • Fatima Alriyami

  • Sara Alzaabi

  • Gamila Ahmed

  • Falah Mohammed AlMarzooqi

  • Saif Al-Shamsi

  • July 7, 2026

  • 0 min

Share

Clinical Scorecard: Exploring Gamification in Education for Genetics, Genomics, and Pharmacogenomics: A Bibliometric Study of Research Trends, Collaborations, and Key Themes (2000–2025)

At a Glance

CategoryDetail
ConditionGamification in Genetics, Genomics, and Pharmacogenomics Education
Key MechanismsUse of game-based elements to enhance learning experiences
Target PopulationHuman learners in educational settings
Care SettingHealth and science education

Key Highlights

  • Increased publication growth in gamification research after 2015
  • Dominance of high-income countries in research output
  • Emphasis on student engagement and interactive learning
  • Limited studies on long-term learning outcomes
  • Emerging interest in pharmacogenomics education

Guideline-Based Recommendations

Diagnosis

    Management

      Monitoring & Follow-up

        Risks

          Patient & Prescribing Data

          Clinical Best Practices

          • Utilize gamification to improve motivation and engagement in learning
          • Incorporate interactive strategies to enhance conceptual understanding
          • Focus on case-based and simulation-based education in pharmacogenomics

          Related Resources & Content

          Original Source(s)

          Gamification in genetics, genomics, and pharmacogenomics education: a bibliometric analysis of research trends, collaboration, and emerging themes (2000–2025)

          • by Azhar T. Rahma, Reem AlSheryani, Noon Hatim Khalid Alrabee, Ahmed Alderei, Alnawa Alharthi, Asma Alshebli, Fatima Alriyami, Sara Alzaabi, Gamila Ahmed, Falah Mohammed AlMarzooqi, Saif Al-Shamsi

          • July 7, 2026

          Related Content

          This Week's CGT News: First Treg Therapy Approved

          First Treg-based cell therapy approved, FDA advanced therapy office faces fresh turnover, and preclinical CAR T studies target rare blood cancers and glioblastoma

          • July 7, 2026

          • 6 min
          A prediction for sepsis in adult patients with severe cerebrovascular disease from neurological intensive care unit

          FDA Approves Atacicept for IgA Nephropathy

          The approval was based on reduced proteinuria, and an ongoing trial is required to determine whether atacicept slows long-term kidney function decline.